• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有计划的环境下实施 HPV 检测以进行宫颈癌筛查:阿根廷胡胡伊省示范项目。

Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina.

机构信息

Consejo Nacional de Investigaciones Científicas y Técnicas/Centro de Estudios de Estado y Sociedad, Sánchez de Bustamante 27, Buenos Aires, Argentina.

Programa Nacional de Prevención de Cáncer Cervicouterino/Instituto Nacional del Cáncer (Argentina), Julio A. Roca 781, Piso 9, Buenos Aires, Argentina.

出版信息

Int J Cancer. 2015 Oct 1;137(7):1709-18. doi: 10.1002/ijc.29530. Epub 2015 Apr 15.

DOI:10.1002/ijc.29530
PMID:25807897
Abstract

The aim of this article is to present results of programmatic introduction of HPV testing with cytologic triage among women 30 years and older in the province of Jujuy, Argentina, including description of the planning phase and results of program performance during the first year. We describe the project implementation process, and calculate key performance indicators using SITAM, the national screening information system. We also compare disease detection rates of HPV testing in 2012 with cytology as performed during the previous year. HPV testing with cytology triage was introduced through a consensus-building process. Key activities included establishment of algorithms and guidelines, creating the HPV laboratory, training of health professionals, information campaigns for women and designing the referral network. By the end of 2012, 100% (n = 270) of public health care centers were offering HPV testing and 22,834 women had been HPV tested, 98.5% (n = 22,515) were 30+. HPV positivity among women over 30 was 12.7%, 807 women were HPV+ and had abnormal cytology, and 281 CIN2+ were identified. CIN2+ detection rates was 1.25 in 2012 and 0.62 in 2011 when the program was cytology based (p = 0.0002). This project showed that effective introduction of HPV testing in programmatic contexts of low-middle income settings is feasible and detects more disease than cytology.

摘要

本文旨在呈现阿根廷胡胡伊省在 30 岁及以上女性中引入 HPV 检测联合细胞学分流策略的项目成果,包括规划阶段的描述和项目实施第一年的结果。我们描述了项目实施过程,并使用国家筛查信息系统(SITAM)计算关键绩效指标。我们还比较了 2012 年 HPV 检测与前一年细胞学检测的疾病检出率。HPV 检测联合细胞学分流策略是通过建立共识的过程引入的。主要活动包括建立算法和指南、建立 HPV 实验室、培训卫生专业人员、为女性开展宣传活动以及设计转诊网络。到 2012 年底,100%(n=270)的公共医疗中心提供 HPV 检测服务,共有 22515 名 30 岁以上的女性接受了 HPV 检测,HPV 阳性率为 12.7%,其中 807 名 HPV 阳性且细胞学异常的女性,以及 281 名 CIN2+患者被识别。2012 年的 CIN2+检出率为 1.25%,而在 2011 年以细胞学为基础的项目中,该比例为 0.62%(p=0.0002)。该项目表明,在中低收入国家的规划背景下,有效引入 HPV 检测是可行的,并且比细胞学检测能检测到更多的疾病。

相似文献

1
Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina.在有计划的环境下实施 HPV 检测以进行宫颈癌筛查:阿根廷胡胡伊省示范项目。
Int J Cancer. 2015 Oct 1;137(7):1709-18. doi: 10.1002/ijc.29530. Epub 2015 Apr 15.
2
Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study.阿根廷胡胡伊省示范项目中宫颈癌预防的人乳头瘤病毒检测:基于人群的前后回顾性队列研究。
Lancet Glob Health. 2019 Jun;7(6):e772-e783. doi: 10.1016/S2214-109X(19)30048-8.
3
Factors associated with low adherence to cervical cancer follow-up retest among HPV+/ cytology negative women: a study in programmatic context in a low-income population in Argentina.与 HPV+/细胞学阴性女性宫颈癌随访复查低依从性相关的因素:在阿根廷低收入人群中,在规划环境下进行的一项研究。
BMC Cancer. 2019 Apr 23;19(1):367. doi: 10.1186/s12885-019-5583-7.
4
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告:基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
5
Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.在实施系统培训和质量控制计划后,对随后被诊断为 CIN1、CIN2/3 和浸润性宫颈癌的女性进行先前的宫颈细胞学和 HR-HPV 检测的结果:4 年的常规临床经验。
BMC Cancer. 2020 Aug 26;20(1):810. doi: 10.1186/s12885-020-07321-2.
6
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
7
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.25 岁及以上女性宫颈癌筛查中致癌型人乳头瘤病毒(HPV)检测及 HPV16 或 HPV18 基因分型的性能:ATHENA 研究的一项亚组分析。
Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.
8
[Real-world research on cervical cancer screening program and effect evaluation for Chinese population].[中国人群宫颈癌筛查项目的真实世界研究及效果评估]
Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):764-771. doi: 10.3760/cma.j.issn.0253-3766.2018.10.008.
9
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.在随机环境中对原发性人乳头瘤病毒筛查与传统细胞学进行特定年龄评估。
J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.
10
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.一项随机对照试验的招募结果,该试验比较了单纯人乳头瘤病毒检测与传统细胞学检查作为主要宫颈癌筛查测试的效果。
J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.

引用本文的文献

1
Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.在阿根廷的项目背景下实施第二轮基于人乳头瘤病毒的宫颈癌筛查。
Rev Panam Salud Publica. 2025 Aug 28;49:e92. doi: 10.26633/RPSP.2025.92. eCollection 2025.
2
[Spatial and spatiotemporal inequalities in premature mortality due to cervical cancer in Argentina (2001-2020)Desigualdades espaciais e espaço-temporais na mortalidade prematura por câncer do colo do útero na Argentina (2001-2020)].[阿根廷宫颈癌所致过早死亡率的空间和时空不平等(2001 - 2020年) 阿根廷宫颈癌所致过早死亡率的空间和时空不平等(2001 - 2020年)]
Rev Panam Salud Publica. 2025 Aug 22;49:e90. doi: 10.26633/RPSP.2025.90. eCollection 2025.
3
Incorporating a mobile application to support communication about HPV testing among women and professionals: barriers and facilitators from the perspective of health professionals in a middle- and low-income setting in Argentina.
引入一款移动应用程序以支持女性与专业人员之间关于人乳头瘤病毒(HPV)检测的沟通:阿根廷中低收入环境下卫生专业人员视角的障碍与促进因素
Ecancermedicalscience. 2024 Sep 25;18:1778. doi: 10.3332/ecancer.2024.1778. eCollection 2024.
4
Implementation of WHO guidelines for cervical cancer screening, diagnosis and treatment: knowledge and perceptions of health providers from Argentina.实施世界卫生组织宫颈癌筛查、诊断和治疗指南:来自阿根廷的卫生提供者的知识和看法。
BMC Cancer. 2024 Aug 12;24(1):996. doi: 10.1186/s12885-024-12650-7.
5
Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand.量化 COVID-19 大流行对癌症筛查计划的影响 - 来自阿根廷、孟加拉国、哥伦比亚、摩洛哥、斯里兰卡和泰国的案例研究。
Elife. 2023 May 16;12:e86527. doi: 10.7554/eLife.86527.
6
[Synthesis of evidence and recommendations: guidelines for cervical cancer screening, detection, and treatmentSíntese de evidências e recomendações: diretrizes para rastreamento, detecção e tratamento do câncer do colo do útero].[证据综合与建议:宫颈癌筛查、检测和治疗指南 宫颈癌筛查、检测和治疗指南的证据综合与建议]
Rev Panam Salud Publica. 2023 Apr 21;47:e72. doi: 10.26633/RPSP.2023.72. eCollection 2023.
7
Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study.在9个拉丁美洲国家实施人乳头瘤病毒检测:ESTAMPA研究中的实验室视角
Front Med (Lausanne). 2022 Nov 17;9:1006038. doi: 10.3389/fmed.2022.1006038. eCollection 2022.
8
Prevention of Cervical Cancer in Low-Resource African Settings.在资源匮乏的非洲环境中预防宫颈癌。
Obstet Gynecol Clin North Am. 2022 Dec;49(4):771-781. doi: 10.1016/j.ogc.2022.08.008.
9
An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation.人乳头瘤病毒(HPV)筛查检测概述:改善弱势群体宫颈癌筛查可及性——从研发到实施
Risk Manag Healthc Policy. 2022 Sep 23;15:1823-1830. doi: 10.2147/RMHP.S296914. eCollection 2022.
10
Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?人乳头瘤病毒检测在拉丁美洲的实施:我们学到了什么;我们本应学到什么,以及我们如何做得更好?
Cancers (Basel). 2022 May 25;14(11):2612. doi: 10.3390/cancers14112612.